Form 4 for NAMS NewAmsterdam Pharma Co N.V.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001193125-26-006658 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-07 | 2026-01-07 | NAMS | Somaiya Mayur Ian | CFO | A - Grant | — | +25.5K | 58.4K | +78% | — |
| DT | 2026-01-07 | 2026-01-05 | NAMS | Somaiya Mayur Ian | CFO | S - Sale | $33.25 | -5,118 | 32.9K | -13% | -$170.2K |
| DT | 2026-01-07 | 2026-01-07 | NAMS | Somaiya Mayur Ian | CFO | A - Grant | $0.00 | +115.0K | 115.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-07 | A | A | 25,500 | — | 58,382 | D | — | — | (F3) Represents RSUs, each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date. (F4) Each RSU was granted on January 7, 2026 for no consideration. |
| 2 | Common | Ordinary Shares | 2026-01-05 | S | D | 5,118 | $33.25 | 32,882 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.77 to $33.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. |
| 3 | Derivative | Option (right to buy) | 2026-01-07 | A | A | 115,000 | $0.00 | 115,000 | D | $35.45 · — to 2036-01-07 | 115,000 Ordinary Shares | (F5) 25% of the shares underlying the option will vest on Janaury 2, 2027, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date. |